Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × Hydroxychloroquine × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 5 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Colorectal Neoplasms 3 Gastrointestinal Neoplasms 2 Sarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1 Arthritis, Rheumatoid 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡